Movement Alert|BABA-W Falls 3.38% in Regular Trading, Analyst Target Price Cut Compounds Capital Outflow Pressure

Market Focus
Oct 02

On October 2, BABA-W declined 3.38% in regular trading, trading at 103.6 HKD/share, with turnover of 877 million HKD. The stock opened lower with a 2.4% gap-down before extending losses amid a confluence of bearish catalysts.

On the news front, multiple headwinds converged. BOCI downgraded BABA-W's target price from 195 HKD to 166 HKD while maintaining a \"Buy\" rating. Southbound capital net sold over 500 million HKD of BABA-W shares on September 29. Meanwhile, CFO Toby Xu disposed of 103,000 shares at $13.68 per share — totaling approximately $1.41 million — for tax withholding purposes following the vesting of restricted stock units. Additionally, the company recently cleared its entire stake in SF Intra-city, cashing out 392 million HKD, and reduced its holding in ZTO Express for roughly $500 million.

Within the Internet & Direct Marketing Retail sector, the overall sector registered broad weakness. Among individual stocks, MEITUAN-W fell 3.07%, JD-SW fell 3.16%, JD HEALTH fell 4.61%, ALI HEALTH fell 1.92%, and PA GOODDOCTOR fell 4.26%, reflecting significant sector-wide selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10